MetLife Investment Management’s Danimer Scientific, Inc. DNMR Stock Holding History

MetLife Investment Management’s Portfolio DNMR Stock Details DNMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,256	Closed	-$104K	–	2873
2023 Q3	$104K	Hold	1,256	–	–	﹤0.01%	2557
2023 Q2	$120K	Buy	1,256 +340	+37%	+$43.6K	﹤0.01%	2579
2023 Q1	$126K	Sell	916 -434	-32%	-$39.7K	﹤0.01%	2457
2022 Q4	$96.6K	Hold	1,350	–	–	﹤0.01%	2606
2022 Q3	$159K	Hold	1,350	–	–	﹤0.01%	2435
2022 Q2	$246K	Hold	1,350	–	–	﹤0.01%	2167
2022 Q1	$316K	Buy	1,350 +482	+56%	+$97.3K	﹤0.01%	2066
2021 Q4	$296K	Buy	868 +218	+34%	+$120K	﹤0.01%	1821
2021 Q3	$425K	Hold	650	–	–	﹤0.01%	1618
2021 Q2	$651K	Buy	+650	New	+$648K	0.01%	1419

Other funds holding DNMR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

JFG

Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CIA

Capital Investment Advisors Atlanta, Georgia $7.59B AUM 23.38% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

MetLife Investment Management's DNMR Position: Q4 2023 in Review

MetLife Investment Management sold out of Danimer Scientific, Inc. (DNMR) in Q4 2023, closing a stake of 1,256 shares — an estimated $104K sold.

MetLife Investment Management first reported a position in DNMR in Q2 2021 and held it in 10 quarters. The position peaked at $651K in Q2 2021. 140 funds tracked by Wall St. Rank hold DNMR as of Q4 2023.

MetLife Investment Management reported no remaining Danimer Scientific, Inc. position as of Q4 2023 after selling out during the quarter.
MetLife Investment Management sold 1,256 Danimer Scientific, Inc. shares in Q4 2023, an estimated $104K.
MetLife Investment Management first reported a position in Danimer Scientific, Inc. in Q2 2021 and held it in 10 quarters.
MetLife Investment Management's Danimer Scientific, Inc. position peaked at $651K in Q2 2021.
140 funds tracked by Wall St. Rank held Danimer Scientific, Inc. as of Q4 2023.

Based on MetLife Investment Management's 13F filing for Q4 2023, filed 14 Feb 2024.